[Research Report] The coronary stents market value is projected to reach US$ 13,879.0 million by 2025 from US$ 7,223.2 million in 2016; it is estimated to grow at a CAGR of 7.8% from 2016 to 2025.
Market Insights and Analyst View:
Coronary stents are small wire mesh tubes used for the restoration of blood flow to the heart by insertion into narrowed or blocked coronary arteries. It supports the artery walls and keeps them open, allowing blood flow. These stents are used in patients with coronary artery disease, a condition in which plaque builds up in the arteries that supply blood to the heart muscle leading to reduced blood flow and potentially life-threatening complications such as heart attack and stroke. The coronary stents market growth is primarily driven by the rising prevalence of coronary artery disease among large population and surge in geriatric population prone to cardiovascular conditions. Moreover, technological advancement, new product launches, product approvals, and increasing investment by major market players are expected to support the coronary stent market growth. Additionally, supportive government policies in the developing economies and increasing awareness about minimally invasive procedures are also expected to create the demand for coronary stents in the near future.
Growth Drivers and Challenges:
The rising population of the elderly people is the major cause of the heart diseases. The heart disease is mostly pone to the elderly people due to weak immunity and major other health problems. For instance, the number of Americans above the age of 65 and older is anticipated to grow more than double from US$ 46 million in 2016 to above US$ 98 million by 2060, and the 65-and-older age group’s share in the world’s population will grow around 24%from 15 percent.
As per World Economic Forum, Europe has the largest percentage of population aging more than 60 or above (30%) in 2022. The fast and rapid ageing is occurring in other parts of the world as well, so that by 2050 all regions of the world except Africa will have nearly a quarter or more of their populations at ages 60 and above. The number of older persons in the world is anticipated to be US$ 1.4 billion in 2030 and US$ 2.1 billion in 2050 and will rise above US$ 3.1 billion in 2100. The elderly population are more prompt to have atypical presentations, comorbid conditions, and unfavourable outcomes. The major reason for the disease is related to the structural and functional changes in the cardiovascular system associated with the aging.
The rising geriatric population in the world leads to the coronary disease which will require the coronary stents for their treatment. These are likely to grow the market in the coming years.
However, Coronary stents are the implantable devices that are placed percutaneous in one or more coronary arteries for maintaining the patency. The various stages of the regulation of the stents require examination at each stage. The clinical evaluation of the drug-eluting stents is majorly aimed to validate the safety and usefulness; and the study design should fulfil both. The end points study for the other settings of coronary drug-eluting stents clinically important to the meaningful endpoints are strongly recommended. The information gathered in the post-marketing period is very important. The long-term (for example, 5-year) post-approval clinical follow-up is very important, and it is recommended. The stringent regulations required for the coronary stents is required for the proper functioning of the stents and accuracy of the coronary stents for the treatment. These are likely to hamper the market growth in near future.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Coronary Stents Market: Strategic Insights
Market Size Value in US$ 7,223.2 Million in 2016 Market Size Value by US$ 13,879.0 Million by 2025 Growth rate CAGR of 7.8% from 2016 to 2025 Forecast Period 2016-2025 Base Year 2016
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Coronary Stents Market: Strategic Insights
| Market Size Value in | US$ 7,223.2 Million in 2016 |
| Market Size Value by | US$ 13,879.0 Million by 2025 |
| Growth rate | CAGR of 7.8% from 2016 to 2025 |
| Forecast Period | 2016-2025 |
| Base Year | 2016 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “Global Coronary Stents Market Size” is segmented based on type, material, absorption rate, distribution channel, and geography. Based on type, the coronary stents market is segmented into drug eluting stents, bare metal stents, and bioabsorbable. Based on material, the coronary stents market is bifurcated into cobalt, platinum, nickel, stainless steel, nitinol, tanalum, polymer, and gold. Based on absorption rate, the coronary stents market is segmented into slow absorption rate and fast absorption rate. Based on end user, the coronary stents market is segmented into e hospitals, cardiac centers, and ambulatory centers. The coronary stents market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Segmental Analysis:
Based on type, the coronary stents market size is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. In 2017, the drug-eluting stents segment held the largest share of the market, by type. In addition, the segment is also expected to grow at the fastest rate during the coming years owing to the advantages of the drug-eluting stents and lower risk of complications. Drug eluting stents are small mesh tubes that have polymer coating over the mesh. These stents emit drug over time to keep the blockage from reoccurring. The drug eluted from the stents prevent the growth of scar tissue in the artery. In addition, these stents are inserted to keep arteries open after the angioplasty procedure ensuring good blood flow. In turn, reducing the risks of heart attack and stroke, and prevent the reoccurrence of any symptoms.
Technological advancement in drug eluting stents market is likely to enhance the products. For instance, in August 2022, Medtronic has launched its newest drug-eluting coronary stent, the Onyx Frontier drug-eluting stent (DES), following recent CE Mark approval. The Onyx Frontier DES offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx drug-eluting stent. The DES leverages the same best-in-class stent platform as Resolute Onyx DES, with an enhanced delivery system designed to improve deliverability and increase acute performance in the most challenging cases. Owing to all the above-mentioned factors, the drug eluting stents market is likely to grow in the coming years.
Coronary Stents Market, by Material – 2017 and 2025
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The coronary stents market will likely grow in the coming years due to all the above-mentioned factors.
Regional Analysis:
Based on geography, the coronary stents market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2017, North America held the largest coronary stents market share closely followed by the Europe, and Asia Pacific is estimated to register the highest CAGR during the forecast period. The growth of European market is primarily driven by the increase in coronary artery disease along with surge in technological advancement and new product launches in the market. Germany is one of the developed countries of the region accounting for major market share in 2017. Germany has many primary care centers for the treatment of the CVD, but the country has still hoped to develop more and more primary care for delivering prevention, early diagnosis and management of CVD and diabetes. For instance, Denmark uses electronic patient records and has shown notable improvements in primary care quality. The primary care system comprises the data for the procedures, diagnoses, prescribed drugs, and laboratory results, providing the proper results for the better results. The growing technological advancements is one of the major factors for the growth of the Germany market for coronary stents. Thus, the market is anticipated to grow significantly during the forecast period due to the above factors.
However, Asia Pacific registered as the fastest-growing region in the global coronary stents market. The market in this region is expected to grow significantly in countries such as China, Japan, and India. The market's growth is attributed to increasing focus of market players in developing economies, and supportive government policies. In addition, the developments of the companies and the mergers and collaborations to form the better opportunities for the users and the manufacturers to the marketing and purchase. Japan has started to grow the primary care and governance across the full pathway of CVD and diabetes care. The benchmarking and monitoring are the most common in primary care. The country has numerous policy instruments for improving the quality of services along the entire pathway, including the integrated care models, financial incentives for improved quality and performance, benchmarking, and target setting.
Furthermore, the technological advances in the medical devices and the increasing government funding are responsible for the product launches and the procedures in the healthcare sector. For instance, the Stent – Save a Life! (SSL) Global Initiative Central Office is joined by China as a new, active member of the SSL Community. The collaboration is for the next three-year, for providing the population the treatment of the CVD using stents. For example, the development of drug-eluting stents, bare metal, bioactive stents, and radioactive stents is anticipated to rise the usage of the stents for the treatment of coronary artery diseases. Additionally, the demand for stents such as biodegradable polymers, bifurcation stents, and bio absorbable scaffolds is expected to increase globally. Advancements in stents will encourage a positive shift in treating coronary artery diseases, thereby propelling the China coronary stent market. Owing to these developments by the industry players in China boost the coronary stents market growth.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global coronary stents market are listed below:
- In April 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc. (CSI), whose atherectomy system is used to treat peripheral and coronary artery disease to prepare vessels for angioplasty or stenting. The transaction provides Abbott with a complementary solution for treating vascular disease.
- In September 2022, Medtronic secured an FDA approval for the use of a new technique in placing its drug-eluting stents, to help treat the build-up of plaques that may clog the junction between two arteries feeding the heart.
- In January 2022, Cook Medical has received Breakthrough Device designation from the US Food and Drug Administration (FDA) on a new drug-eluting stent for below the knee (BTK). This new stent is designed to treat patients suffering from chronic limb-threatening ischemia (CLTI).
Competitive Landscape and Key Companies:
Some of the prominent players operating in the global coronary stents market include Abbott Laboratories, Medtronic PLC., and Boston Scientific Corporation, Teromo Corporation, B. Braun Melsungen AG, Biosensors International Group, Ltd., B. Braun Melsungen AG, Vascular Concepts Limited, and Microport Scientific Corporation among others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, allowing them to serve a large set of customers and subsequently increase their market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Absorption Rate, Material, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
Coronary stents are a kind of little mesh metal tubes that are developed for providing support to the weakened arteries within the heart.
Factors like the rising prevalence of arteria coronaria diseases, technological advancements and rising geriatric population are anticipated to drive the expansion of the market.
APAC region is most lucrative for the coronary stents market and the same is growing with CAGR of 10.8% during forecast period.
The surgery for CVD, coronary heart diseases and different heart ailments want treatments for a much better and healthy lifestyle. The price of coronary stents is that the most important issue that is taken into account before using stents. However, the cost of the stents is declining within the previous couple of years that becomes one amongst the first reasons for a lot of procedures to be performed.
The List of Companies - Coronary Stents Market
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Coronary Stents Market
Apr 2018
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2018
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2018
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2018
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2018
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2018
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2018
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2018
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)